Shanshan Xu

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Boston, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jonathan I. Lieber, as attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Shanshan Xu

Form 4 holding Co-Founder, Chief Executive Officer, President, and Chairperson, Director, 10%+ Owner

Bambusa Therapeutics, Inc.

Security class
Common Stock
Shares / value
7,562,518
Estimated value
Report date
02 Nov 2026
Price
Ownership
Indirect
Form 4 holding Co-Founder, Chief Executive Officer, President, and Chairperson, Director, 10%+ Owner

Bambusa Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
758,204
Estimated value
Report date
29 Oct 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Co-Founder, Chief Executive Officer, President, and Chairperson, Director, 10%+ Owner

Bambusa Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
379,102
Estimated value
Report date
29 Oct 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Co-Founder, Chief Executive Officer, President, and Chairperson, Director, 10%+ Owner

Bambusa Therapeutics, Inc.

Security class
Series A-1 Preferred Stock
Shares / value
0
Estimated value
Report date
02 Nov 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Co-Founder, Chief Executive Officer, President, and Chairperson, Director, 10%+ Owner

Bambusa Therapeutics, Inc.

Security class
Series Seed Plus Preferred Stock
Shares / value
0
Estimated value
Report date
02 Nov 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Co-Founder, Chief Executive Officer, President, and Chairperson, Director, 10%+ Owner

Bambusa Therapeutics, Inc.

Security class
Series Seed Preferred Stock
Shares / value
0
Estimated value
Report date
02 Nov 2026
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Shanshan Xu

3

Bambusa Therapeutics, Inc.

Report period
29 Oct 2026
Transactions
0
Transaction value
$0
Accepted by SEC
29 Oct 2026, 16:26
Role
Co-Founder, Chief Executive Officer, President, and Chairperson; Exhibit 24 - Power of Attorney, Director, 10%+ Owner
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .